Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
COV [NYSE]
Covidien plc
IndexS&P 500 P/E25.54 EPS (ttm)3.48 Insider Own0.20% Shs Outstand450.88M Perf Week-1.78%
Market Cap40.08B Forward P/E19.98 EPS next Y4.45 Insider Trans-4.65% Shs Float446.39M Perf Month-1.35%
Income1.60B PEG2.73 EPS next Q1.00 Inst Own99.80% Short Float0.66% Perf Quarter25.92%
Sales10.38B P/S3.86 EPS this Y0.90% Inst Trans11.21% Short Ratio0.60 Perf Half Y31.55%
Book/sh21.20 P/B4.19 EPS next Y11.48% ROA8.00% Target Price88.89 Perf Year47.98%
Cash/sh2.61 P/C34.02 EPS next 5Y9.36% ROE17.00% 52W Range58.32 - 92.68 Perf YTD31.73%
Dividend1.28 P/FCF30.29 EPS past 5Y3.50% ROI11.90% 52W High-4.09% Beta1.04
Dividend %1.44% Quick Ratio1.50 Sales past 5Y0.60% Gross Margin58.80% 52W Low52.41% ATR1.75
Employees38500 Current Ratio2.00 Sales Q/Q2.70% Oper. Margin20.40% RSI (14)58.32 Volatility1.67% 1.18%
OptionableYes Debt/Eq0.53 EPS Q/Q21.30% Profit Margin15.50% Rel Volume1.11 Prev Close88.53
ShortableYes LT Debt/Eq0.52 EarningsJul 25 BMO Payout34.70% Avg Volume4.91M Price88.89
Recom2.50 SMA20-1.63% SMA509.44% SMA20025.11% Volume5,454,435 Change0.41%
17-Jul-14Downgrade Needham Buy → Hold
18-Jun-14Downgrade Barclays Overweight → Equal Weight $82 → $93
16-Jun-14Reiterated Brean Capital Buy $75 → $93.22
16-Jun-14Downgrade CRT Capital Buy → Fair Value $82 → $93.22
06-Mar-14Reiterated Barclays Overweight $77 → $82
26-Feb-14Initiated CRT Capital Buy $82
27-Jan-14Reiterated Deutsche Bank Buy $75 → $77
14-Jan-14Reiterated RBC Capital Mkts Sector Perform $65 → $70
05-Dec-13Reiterated Barclays Overweight $72 → $77
05-Dec-13Initiated The Benchmark Company Buy $82
11-Nov-13Reiterated Needham Buy $69 → $74
08-Nov-13Reiterated Needham Buy $69 → $74
04-Sep-13Initiated Needham Hold $69
02-Aug-13Reiterated Barclays Overweight $67 → $72
01-Jul-13Reiterated Deutsche Bank Buy $74 → $68
29-May-13Reiterated Mizuho Buy $70 → $76
07-May-13Reiterated Barclays Overweight $70 → $74
12-Apr-13Reiterated Deutsche Bank Buy $70 → $74
20-Mar-13Reiterated RBC Capital Mkts Sector Perform $66 → $69
04-Feb-13Reiterated RBC Capital Mkts Sector Perform $59 → $66
22-Jul-14 02:04PM  Senate Panel Takes On Tax Inversions at New York Times
11:02AM  Bovie Medical: Little Bovie May Be Running With The Big Dogs at Seeking Alpha
07:04AM  COVIDIEN PLC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial State EDGAR Online
07:00AM  Covidien Announces Leadership Appointment Business Wire
21-Jul-14 04:42PM  [video] Covidien, Williams Companies Offer Dynamic Dividend Plays at TheStreet
11:34AM  Tax inversions allow firms to avoid state taxes at USA TODAY
18-Jul-14 12:51PM  Key GOP senator signals readiness for inversion deal, The Hill says theflyonthewall.com
17-Jul-14 05:32PM  Covidien Unveils Advanced Ablation Device for Liver Tumor Zacks
01:04PM  COVIDIEN PLC Financials EDGAR Online Financials
06:02AM  Covidien downgraded by Needham Briefing.com
16-Jul-14 04:05PM  Covidien Declares Quarterly Cash Dividend Business Wire
11:03AM  Covidien (COV) Showing Signs Of Being Water-Logged And Getting Wetter at TheStreet
09:30AM  Treasury Urges End to Foreign Tax Flights, Though Congress Is Unlikely to Act Soon at New York Times
09:30AM  Treasury Urges End to Foreign Tax Flights, but Quick Action Is Unlikely at New York Times
09:30AM  Obama Administration Seeks End to Inversion Deals at New York Times
07:27AM  Covidien Makes Liver Tumor Ablation More Predictable Business Wire
14-Jul-14 05:20PM  Stryker Continues Growth Spree via Acquisitions Zacks
01:46PM  Shorts Are Piling Into These Stocks. Should You Be Worried? at Motley Fool
08:30AM  Announcement under Irish Takeover Rules Relevant Securities in Issue July 14, 2014 Business Wire
05:51AM  Should You Avoid The 5 Lowest Yielding Dividend Aristocrats? at Seeking Alpha
13-Jul-14 08:06AM  Tax Inversions: Why Are They So Popular? at Motley Fool
11-Jul-14 06:39AM  COVIDIEN PLC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements an EDGAR Online
09-Jul-14 03:46PM  Has Johnson & Johnson Finally Met Its Match? at Seeking Alpha
12:03PM  Salix Pharmaceuticals to Buy Irish Company and Reincorporate Overseas at New York Times
08-Jul-14 03:11PM  Tax Inversions: A Look at Five Cross-Border Deals With Big Price Tags at The Wall Street Journal
02:37PM  Tax Inversions: A Look at Five Cross-Border Deals with Big Price Tags at The Wall Street Journal
12:17PM  Deutsche Bank Reiterates On Medtronic And Covidien Amid Acquisition Proposal Benzinga
10:13AM  [$$] AbbVie Raises Offer for Shire at The Wall Street Journal
08:50AM  [$$] AbbVie Raises Offer for Shire at The Wall Street Journal
07-Jul-14 01:00PM  Is the IntegrysWisconsin Energy merger a do for investors? Market Realist
12:23PM  Companies Look Overseas for Acquisitions and Lower Taxes at The Wall Street Journal
10:45AM  Moody's: Healthcare Quarterly looks at credit implications of M&A surge in industry at Moody's
09:00AM  Why consider possible IntegrysWisconsin Energy merger scenarios? Market Realist
03-Jul-14 05:00PM  Background on Wisconsin Energy can help you with the Integrys deal Market Realist
01:00PM  Background on Integrys can help you with the Wisconsin Energy deal Market Realist
09:00AM  The strategic rationale for the IntegrysWisconsin Energy deal Market Realist
02-Jul-14 01:54PM  Should you get involved in the IntegrysWisconsin Energy deal? Market Realist
01:01PM  The Fleeting Benefits of Overseas Corporate Marriages at New York Times
11:14AM  Johnson & Johnson Unit Whacks 400 Jobs as Part of Reorganization at The Wall Street Journal
10:22AM  Johnson & Johnson Unit Whacks 400 Jobs as Part of Reorganization at The Wall Street Journal
01-Jul-14 08:21AM  Covidien (COV) is in Overbought Territory: What's Next? Zacks
30-Jun-14 08:30AM  Announcement under Irish Takeover Rules Relevant Securities in Issue June 30, 2014 Business Wire
28-Jun-14 07:00AM  Stock-Picking Increasingly Critical in Health Care Morningstar
27-Jun-14 01:00PM  Why the government could torpedo the Covidien-Medtronic deal Market Realist
01:00PM  Why the government could torpedo the Covidien-Medtronic deal
09:00AM  The must-know political risk to the Covidien-Medtronic deal Market Realist
09:00AM  The must-know political risk to the Covidien-Medtronic deal
26-Jun-14 05:00PM  The Covidien-Medtronic merger: Consider these possible outcomes Market Realist
05:00PM  The Covidien-Medtronic merger: Consider these possible outcomes
01:00PM  Antitrust approvals: Assessing the Covidien-Medtronic merger Market Realist
01:00PM  Antitrust approvals: Assessing the Covidien-Medtronic merger
12:27PM  [$$] Profiting From Weakness in Washington
09:20AM  Medtronic Covets Covidien, But It Could Do So Much Better at Seeking Alpha
09:20AM  Medtronic Covets Covidien, But It Could Do So Much Better
09:00AM  Merger must-know: Covidiens material adverse effect clause Market Realist
09:00AM  Merger must-know: Covidiens material adverse effect clause
07:00AM  Covidien plc to Report Third-Quarter Fiscal 2014 Results on July 25, 2014 Business Wire
07:00AM  Covidien plc to Report Third-Quarter Fiscal 2014 Results on July 25, 2014
25-Jun-14 05:00PM  The Covidien-Medtronic merger: Key background on Medtronic Market Realist
05:00PM  The Covidien-Medtronic merger: Key background on Medtronic
01:00PM  The Covidien-Medtronic merger: Key background on Covidien Market Realist
01:00PM  The Covidien-Medtronic merger: Key background on Covidien
12:15PM  Patent Infringement War Continues Between Covidien and J&J Unit
09:00AM  Understanding the rationale for the Covidien-Medtronic transaction
08:49AM  CONMED: Aggressive Accounting And Increased Debt Mask Its Problems
24-Jun-14 05:39PM  Key overview: Merger arbitrage and the Covidien-Medtronic deal
01:40PM  Why the government could torpedo the Covidien-Medtronic deal
01:38PM  Spread analysis: Does the Covidien-Medtronic merger make sense?
12:40PM  Covidien Launches New PED to Treat Brain Aneurysm
08:30AM  Announcement under Irish Takeover Rules Relevant Securities in Issue June 24, 2014
08:09AM  [$$] Covidien Again Sues J&J Unit Over Surgical-Tool Patents
07:30AM  Covidien Files Patent Infringement Lawsuit over Ethicon's Ultrasonic Surgical Devices
07:12AM  Ernst & Youngs Jeanneret Says U.S. Leading M&A Rebound (Audio)
12:01AM  Covidien Announces European Launch of Pipeline Flex Embolization Device
21-Jun-14 11:35AM  Why Covidien, Williams Companies, and CarMax Soared Last Week
09:02AM  3 Stocks That Soared Stupendously This Week
03:47AM  [$$] Review
03:21AM  [$$] Buybacks Surge, Led by Apple
02:40AM  [$$] Charting the Market
20-Jun-14 05:17PM  Shire nixes $46B bid from U.S. drug giant AbbVie at USA TODAY
05:17PM  Shire nixes $46B bid from U.S. drug giant AbbVie
02:27PM  Shire nixes $46B bid from U.S. drug giant AbbVie at USA TODAY
12:15PM  Medtronic says was victim of cyber attack, lost patient records Reuters
11:26AM  Medtronic says was victim of cyber attack, lost patient records Reuters
11:05AM  Shire nixes $46B bid from U.S. drug giant AbbVie at USA TODAY
09:16AM  Shire nixes $46B bid from U.S. drug giant AbbVie at USA TODAY
08:32AM  Shire nixes $46B bid from U.S. drug giant AbbVie at USA TODAY
08:30AM  Announcement under Irish Takeover Rules Relevant Securities in Issue Business Wire
08:30AM  Announcement under Irish Takeover Rules Relevant Securities in Issue
07:34AM  AbbVie - Attempt To Acquire Shire Is Driven By Opportunistic Tax Synergies at Seeking Alpha
07:34AM  AbbVie - Attempt To Acquire Shire Is Driven By Opportunistic Tax Synergies
06:33AM  The Morning Ledger: Tax Inversions Pose Challenges in Execution at The Wall Street Journal
05:43AM  Drug Maker Shire Rejects Offer From AbbVie Worth about $46 Billion at New York Times
19-Jun-14 07:26PM  3 Key Opportunities for Medtronic and Covidien at Motley Fool
07:26PM  3 Key Opportunities for Medtronic and Covidien
05:38AM  Tax Inversion May Lead To Greater Profits For These High-Growth Stocks at Seeking Alpha
18-Jun-14 05:12PM  Medtronic vs. Johnson & Johnson: Meet the Market's Biggest New Rivalry at Motley Fool
05:12PM  Medtronic vs. Johnson & Johnson: Meet the Market's Biggest New Rivalry
03:03PM  Abnormal Volume Stocks To Watch On Wednesday at Forbes
01:45PM  3 Stocks to Get on Your Watchlist at Motley Fool
Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. The company's Medical Devices segment develops, manufactures, and sells endomechanical instruments, such as laparoscopic instruments, surgical staplers, and interventional lung solutions; energy devices, including vessel sealing, electrosurgical, and ablation products and related capital equipment; and soft tissue repair products comprising sutures, mesh, biosurgery products, and hernia mechanical devices. This segment also offers vascular products, such as compression, dialysis, venous insufficiency, thrombectomy, neurovascular, and peripheral vascular products; oximetry and monitoring products, including sensors, monitors, and temperature management products; and airway and ventilation products comprising airway, ventilator, breathing systems, and inhalation therapy products. Its products are used primarily by hospitals and ambulatory care centers, as well as alternate site healthcare providers, such as physician offices. The company's Medical Supplies segment develops, manufactures, and distributes nursing care products comprising incontinence, wound care, enteral feeding, urology, and suction products; medical surgical products, such as operating room supply products related accessories, electrodes, thermometry, and chart paper product lines; SharpSafety products, including needles, syringes, and sharps disposal products; and original equipment manufacturer products. Its products are used primarily in hospitals, surgi-centers, and alternate care facilities, such as homecare and long-term care facilities. The company markets its products through direct sales force and third-party distributors. Covidien plc is based in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
King Brian DouglasVice PresidentApr 29Option Exercise48.4315,569754,03752,742Apr 30 04:06 PM
King Brian DouglasVice PresidentApr 29Sale70.1115,5691,091,48337,173Apr 30 04:06 PM
Dockendorff Charles JEVP & Chief Financial OfficerMar 28Option Exercise39.3290,7303,567,504202,861Mar 28 04:56 PM
Dockendorff Charles JEVP & Chief Financial OfficerMar 28Sale72.5090,7306,577,925112,131Mar 28 04:56 PM
ALMEIDA JOSE EPresident and Chief ExecutiveFeb 28Option Exercise39.3250,0001,966,000263,750Mar 03 04:03 PM
ALMEIDA JOSE EPresident and Chief ExecutiveFeb 28Sale72.0050,0003,600,000213,750Mar 03 04:03 PM
Lannum Coleman N IIIVice PresidentFeb 18Option Exercise44.393,200142,0329,838Feb 20 04:05 PM
Lannum Coleman N IIIVice PresidentFeb 18Sale71.403,200228,4836,638Feb 20 04:05 PM
BROWN RICHARD G JRVice President and ControllerFeb 13Sale71.004,000284,00054,040Feb 14 04:13 PM
Lannum Coleman N IIIVice PresidentFeb 12Sale70.3350035,1656,603Feb 12 04:04 PM
Wehrly Peter LSenior Vice PresidentFeb 11Option Exercise39.188,286324,64552,923Feb 12 04:04 PM
King Brian DouglasVice PresidentFeb 11Option Exercise40.9117,946734,13655,057Feb 12 04:04 PM
Hanson Bryan CSenior Vice PresidentFeb 11Option Exercise52.5315,960838,37958,814Feb 12 04:04 PM
King Brian DouglasVice PresidentFeb 11Sale70.0017,9461,256,22037,111Feb 12 04:04 PM
Hanson Bryan CSenior Vice PresidentFeb 11Sale69.9732,4802,272,75626,334Feb 12 04:04 PM
Lannum Coleman N IIIVice PresidentFeb 11Sale70.1146132,3217,103Feb 12 04:04 PM
Wehrly Peter LSenior Vice PresidentFeb 11Sale69.978,286579,75444,637Feb 12 04:04 PM
Lannum Coleman N IIIVice PresidentJan 29Sale68.661,00569,0037,564Jan 30 04:02 PM
Lannum Coleman N IIIVice PresidentJan 28Option Exercise43.4112,782554,83921,351Jan 30 04:02 PM
Lannum Coleman N IIIVice PresidentJan 28Sale69.2812,782885,4868,569Jan 30 04:02 PM
BROWN RICHARD G JRVice President and ControllerJan 24Sale70.004,000280,00058,040Jan 24 04:03 PM
Dockendorff Charles JEVP & Chief Financial OfficerJan 10Option Exercise39.3290,0003,538,800202,027Jan 10 04:09 PM
Dockendorff Charles JEVP & Chief Financial OfficerJan 10Sale69.5090,0006,255,000112,027Jan 10 04:09 PM
ALMEIDA JOSE EPresident and Chief ExecutiveJan 09Option Exercise39.3250,0001,966,000263,154Jan 10 04:09 PM
BROWN RICHARD G JRVice President and ControllerJan 09Sale69.004,000276,00061,868Jan 10 04:09 PM
ALMEIDA JOSE EPresident and Chief ExecutiveJan 09Sale69.0050,0003,450,000213,154Jan 10 04:09 PM
BROWN RICHARD G JRVice President and ControllerDec 27Sale68.004,000272,00065,868Dec 31 02:06 PM
King Brian DouglasVice PresidentDec 16Sale66.505,000332,50037,028Dec 16 04:37 PM
Green Eric CVice PresidentDec 09Option Exercise43.444,680203,29917,642Dec 10 04:09 PM
Masterson John HSVP and General CounselDec 09Option Exercise41.4538,0931,578,771110,300Dec 09 04:18 PM
Masterson John HSVP and General CounselDec 09Sale68.5138,0932,609,77472,207Dec 09 04:18 PM
Green Eric CVice PresidentDec 09Sale68.464,680320,39312,962Dec 10 04:09 PM
Clemmer James CSenior Vice PresidentDec 06Option Exercise41.3543,6071,803,15680,915Dec 09 04:04 PM
Clemmer James CSenior Vice PresidentDec 06Sale67.8543,6072,958,71837,308Dec 09 04:04 PM
Sgrignari MichaelSenior Vice PresidentDec 05Option Exercise44.3023,2771,031,25751,562Dec 05 04:11 PM
Sgrignari MichaelSenior Vice PresidentDec 05Sale67.3323,2771,567,19928,285Dec 05 04:11 PM
Masterson John HSVP and General CounselDec 04Sale66.9939126,19372,207Dec 04 04:23 PM
Hanson Bryan CSenior Vice PresidentDec 02Option Exercise41.7036,8571,536,83673,737Dec 04 04:23 PM
Hanson Bryan CSenior Vice PresidentDec 02Sale68.0036,8572,506,27643,696Dec 04 04:23 PM
Wendell Amy McBrideSenior Vice PresidentNov 26Option Exercise39.3214,000550,48050,626Nov 27 01:48 PM
Green Eric CVice PresidentNov 26Option Exercise43.4414,039609,85426,765Nov 27 01:48 PM
Wendell Amy McBrideSenior Vice PresidentNov 26Sale68.0014,000952,00036,626Nov 27 01:48 PM
Green Eric CVice PresidentNov 26Sale68.4614,039961,11012,726Nov 27 01:48 PM
Wehrly Peter LSenior Vice PresidentNov 22Option Exercise29.534,409130,19845,423Nov 22 04:04 PM
Wehrly Peter LSenior Vice PresidentNov 22Sale66.824,409294,61541,014Nov 22 04:04 PM
BRUST ROBERT HDirectorNov 21Option Exercise39.3210,521413,68618,738Nov 22 04:03 PM
BRUST ROBERT HDirectorNov 21Sale66.6810,521701,4968,217Nov 22 04:03 PM
Dockendorff Charles JEVP & Chief Financial OfficerNov 15Sale66.2239,3972,609,023111,273Nov 15 04:03 PM
Wendell Amy McBrideSenior Vice PresidentNov 14Option Exercise39.3214,000550,48050,626Nov 15 04:03 PM
Hanson Bryan CSenior Vice PresidentNov 14Option Exercise49.482,889142,94831,765Nov 15 04:03 PM
ALMEIDA JOSE EPresident and Chief ExecutiveNov 14Sale66.0017,5001,155,000200,566Nov 15 04:03 PM
Lannum Coleman N IIIVice PresidentNov 14Sale65.495,707373,7567,374Nov 15 04:03 PM
Hanson Bryan CSenior Vice PresidentNov 14Sale66.162,889191,14128,876Nov 15 04:03 PM
Wendell Amy McBrideSenior Vice PresidentNov 14Sale66.0014,000924,00036,626Nov 15 04:03 PM
Green Eric CVice PresidentNov 13Sale65.007,392480,48012,726Nov 15 04:03 PM
Wendell Amy McBrideSenior Vice PresidentNov 12Sale64.3117,2091,106,70436,626Nov 13 04:02 PM
King Brian DouglasVice PresidentNov 12Sale64.255,000321,25028,465Nov 13 04:02 PM
Wehrly Peter LSenior Vice PresidentOct 23Option Exercise39.188,285324,60638,140Oct 25 04:03 PM
Dunford Michael PSenior Vice PresidentOct 23Option Exercise35.5410,251364,36732,706Oct 25 04:03 PM
Wehrly Peter LSenior Vice PresidentOct 23Sale64.738,285536,28829,855Oct 25 04:03 PM
Dunford Michael PSenior Vice PresidentOct 23Sale65.0010,251666,31522,455Oct 25 04:03 PM
ALMEIDA JOSE EPresident and Chief ExecutiveOct 22Sale64.0017,5001,120,000217,406Oct 22 04:07 PM
Green Eric CVice PresidentSep 30Sale60.843,440209,30020,093Oct 01 04:05 PM
Masterson John HSVP and General CounselAug 09Option Exercise43.2047,2332,040,532110,123Aug 12 04:11 PM
Masterson John HSVP and General CounselAug 09Sale63.6947,2333,008,11462,890Aug 12 04:11 PM
Wendell Amy McBrideSenior Vice PresidentAug 08Option Exercise31.1617,081532,24469,263Aug 12 04:11 PM
Masterson John HSVP and General CounselAug 08Option Exercise39.1830,3831,190,40693,273Aug 12 04:11 PM
Green Eric CVice PresidentAug 08Option Exercise34.858,531297,30528,445Aug 12 04:11 PM
Wendell Amy McBrideSenior Vice PresidentAug 08Sale63.8925,0811,602,51044,182Aug 12 04:11 PM
Masterson John HSVP and General CounselAug 08Sale63.9030,3831,941,47462,890Aug 12 04:11 PM
Dunford Michael PSenior Vice PresidentAug 08Sale63.828,200523,30318,060Aug 12 04:11 PM
Green Eric CVice PresidentAug 08Sale63.878,531544,90119,914Aug 12 04:11 PM
Dockendorff Charles JEVP & Chief Financial OfficerAug 08Sale63.7139124,911137,819Aug 08 04:44 PM
BROWN RICHARD G JRVice President and ControllerAug 07Option Exercise38.2143,0211,643,94697,962Aug 08 04:44 PM
Dockendorff Charles JEVP & Chief Financial OfficerAug 07Option Exercise35.8594,7973,398,644233,007Aug 08 04:44 PM
Dockendorff Charles JEVP & Chief Financial OfficerAug 07Sale63.1594,7975,986,269138,210Aug 08 04:44 PM
BROWN RICHARD G JRVice President and ControllerAug 07Sale63.4331,6972,010,46566,265Aug 08 04:44 PM
Wehrly Peter LSenior Vice PresidentAug 01Option Exercise39.188,286324,64533,275Aug 05 04:08 PM
Wehrly Peter LSenior Vice PresidentAug 01Sale62.928,286521,35524,989Aug 05 04:08 PM